Karen A. Foster - 28 Dec 2022 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
Chief Quality Officer
Signature
/s/ Karen A. Foster
Issuer symbol
BLFS
Transactions as of
28 Dec 2022
Net transactions value
-$10,224
Form type
4
Filing time
30 Dec 2022, 18:04:36 UTC
Previous filing
30 Nov 2022
Next filing
10 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock Sale $10,224 -605 -0.56% $16.90 107,811 28 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.